MILLENNIUM

Serial Number 75453189
606

Registration Progress

Application Filed
Mar 19, 1998
Under Examination
Dec 8, 1998
Approved for Publication
Aug 14, 1998
Published for Opposition
Sep 15, 1998
Registered

Trademark Image

MILLENNIUM

Basic Information

Serial Number
75453189
Filing Date
March 19, 1998
Published for Opposition
September 15, 1998
Abandonment Date
December 9, 2001
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 9, 2001
Classes
042

Rights Holder

Millennium Pharmaceuticals, Inc.

03
Address
238 Main Street, 5th Floor
Cambridge, MA 02142

Ownership History

Millennium Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Millennium Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
MICHAEL J BEVILACQUA

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

17 events
Date Code Type Description Documents
Mar 6, 2002 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 7, 2001 EXT5 S SOU EXTENSION 5 FILED Loading...
Jun 7, 2001 EX5G S SOU EXTENSION 5 GRANTED Loading...
Apr 12, 2001 EX4G S SOU EXTENSION 4 GRANTED Loading...
Dec 7, 2000 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 8, 2000 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 8, 2000 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 3, 2000 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 8, 1999 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 8, 1999 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 8, 1999 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 8, 1998 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 15, 1998 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 14, 1998 NPUB O NOTICE OF PUBLICATION Loading...
Jul 8, 1998 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 1, 1998 CNEA F EXAMINER'S AMENDMENT MAILED Loading...
Jun 29, 1998 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 042
medical and diagnostic services, namely, diagnosing, preventing, and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
042